Clinical Trial Update: A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD [Phase 1, Phase 2]

View source ↗

Summary

This document reports a Phase 1/2 safety and pharmacokinetics trial of VO659 in Spinocerebellar ataxia type 1, spinocerebellar ataxia type 3, and Huntington dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease
• Spinocerebellar Ataxia Type

Drugs mentioned

• VO659

Snippet

Sponsor: Vico Therapeutics B. V. | Conditions: Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3 | Phase 1, Phase 2 | Status: RECRUITING